spacer
The Healthcare Sales & Marketing Network celebrates 24 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  linaclotide 

 HSMN NewsFeed - 20 Feb 2020
Kallyope Inc. Appoints Peter Hecht to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Oct 2015
Allergan Acquires Rights To Ironwood's CONSTELLA(R) (Linaclotide) From Almirall In More Than 40 Countries
Biopharmaceuticals Gastroenterology Acquisitions
 HSMN NewsFeed - 8 Jan 2014
Ironwood Pharmaceuticals Announces Alignment of Workforce with Priority Growth Platforms
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 21 Aug 2013
Ironwood Pharmaceuticals Appoints Dr. Michael Hall as Senior Vice President of Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Mar 2013
Ironwood Pharmaceuticals Appoints Edward Owens to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Feb 2013
Ironwood Pharmaceuticals Promotes Dr. Mark Currie to Senior Vice President, Chief Scientific Officer, and President of R&D
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Nov 2012
Constella(R) (linaclotide) Approved in Europe for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in Adults
Biopharmaceuticals Gastroenterology Regulatory
 HSMN NewsFeed - 20 Apr 2011
Mersana Therapeutics Appoints Michael A. Metzger as EVP & COO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Nov 2009
Ironwood and Astellas Announce Japan Licensing Agreement for Linaclotide
Biopharmaceuticals Licensing
 HSMN NewsFeed - 14 Sep 2009
Ironwood Appoints Thomas McCourt As Chief Commercial Officer and Senior Vice President of Marketing and Sales
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 May 2009
Ironwood Announces Linaclotide European Licensing Agreement with Almirall
Biopharmaceuticals Gastroenterology Licensing
 HSMN NewsFeed - 7 Apr 2008
Microbia Announces Name Change to Ironwood Pharmaceuticals
Biopharmaceuticals
 HSMN NewsFeed - 8 Jan 2008
Callisto Pharmaceuticals Announces Investor Conference Call to Provide Details on Guanilib Strategic Initiative in GI Disorders
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 17 Sep 2007
Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration
Biopharmaceuticals Gastroenterology
Return to NewsFeed  
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.